1-9 of 9
Ling-Hua Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lenalidomide Efficacy in Activated B-Cell-Like Subtype Diffuse Large B-Cell Lymphoma Is Dependent Upon IRF4 and Cereblon Expression

Ling-Hua Zhang, PhD, Jolanta Kosek, BA, Maria Wang, Ph.D., Carla Heise, PhD, Peter H Schafer, PhD, Rajesh Chopra, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3287.
https://doi.org/10.1182/blood.V120.21.3287.3287
Published: 2012
Journal Articles

CC-122 Is a Novel Pleiotropic Pathway Modifier with Potent in Vitro Immunomodulatory and Anti-Angiogenic Properties and in Vivo Anti-Tumor Activity in Hematological Cancers.

Anita K Gandhi, PhD, Derek Mendy, BS, Anastasia Parton, BA, Lei Wu, MS, ECFMG, Jolanta Kosek, BA, Ling-Hua Zhang, PhD, Lori Capone, BS, Antonia Lopez-Girona, PhD, Peter H Schafer, PhD, Rajesh Chopra, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2963.
https://doi.org/10.1182/blood.V120.21.2963.2963
Published: 2012
Journal Articles

Lenalidomide Inhibits Multiple Myeloma Cell Proliferation in Vitro Via Its Effect On Expression of Oncogenes and Tumor Suppressor Genes.

Ling-Hua Zhang, Mary Adams, Jolanta Kosek, Peter H Schafer, J. Blake Bartlett
Journal: Blood
Blood (2009) 114 (22): 2855.
https://doi.org/10.1182/blood.V114.22.2855.2855
Published: 2009
Journal Articles

Opposing Effects of Dexamethasone on Lenalidomide Activity in Multiple Myeloma: Additive/Synergistic Effects on Anti-Proliferative Activity on Myeloma Cells and Antagonistic Effects on Immune Function

Peter H Schafer, Anita K Gandhi, Ling-Hua Zhang, Jian Kang, Lori Capone, Stacey Parton, Lei Wu, Blake Bartlett
Journal: Blood
Blood (2008) 112 (11): 2761.
https://doi.org/10.1182/blood.V112.11.2761.2761
Published: 2008
Journal Articles

Direct Inhibitory Effects of Lenalidomide on the Proliferation and VEGF Production of Non-Hodgkin Lymphoma Cells Are Associated with Increased SPARC Expression

Ling-Hua Zhang, Peter H Schafer, George Muller, David Stirling, Blake Bartlett
Journal: Blood
Blood (2008) 112 (11): 2612.
https://doi.org/10.1182/blood.V112.11.2612.2612
Published: 2008
Journal Articles

Antiproliferative Effects of Lenalidomide in Combination with Chemotherapeutic Agents in Lymphoma Cell Lines

Anita K Gandhi, Jian Kang, Lori Capone, Ling-Hua Zhang, Blake Bartlett, Dennis Pietronegro, Annette Ervin-Haynes, Peter H Schafer
Journal: Blood
Blood (2008) 112 (11): 4990.
https://doi.org/10.1182/blood.V112.11.4990.4990
Published: 2008
Journal Articles

Lenalidomide Displays Direct Anti-Non-Hodgkin’s Lymphoma (NHL) Cell Activity in Association with Enhanced SPARC Expression but Independent of Its Ability to Strongly Inhibit NHL Cell VEGF Production In Vitro .

Ling-Hua Zhang, PhD, Peter Schafer, PhD, George Muller, PhD, David Stirling, PhD, J. Blake Bartlett, PhD
Journal: Blood
Blood (2007) 110 (11): 3473.
https://doi.org/10.1182/blood.V110.11.3473.3473
Published: 2007
Journal Articles

Lenalidomide Displays Anti-Proliferative Activity and Combination Effects with Chemotherapeutic Agents Against a Burkitt’s Lymphoma Cell Line.

Anita K. Gandhi, PhD, Jian Kang, BS, Ling-Hua Zhang, PhD, Blake Bartlett, PhD, Peter H. Schafer, PhD, David I. Stirling, PhD
Journal: Blood
Blood (2007) 110 (11): 4516.
https://doi.org/10.1182/blood.V110.11.4516.4516
Published: 2007
Journal Articles

Comparison of Anti-Angiogenic Activities of Thalidomide and Lenalidomide In Vitro.

Ling-Hua Zhang, PhD, Ling Lu, MS, Lei Wu, MS, Keith Dredge, PhD, J. Blake Bartlett, PhD, Peter Schafer, PhD, George Muller, PhD, Angus Dalgleish, PhD, David Stirling, PhD
Journal: Blood
Blood (2005) 106 (11): 3959.
https://doi.org/10.1182/blood.V106.11.3959.3959
Published: 2005